The Effect of Therapeutic Ultrasound on Angiogenesis and Perfusion in a Rat Model of Femoral Ischemia

Offir Ertracht 1 Nava Salman Kesner 1,3 Hila Nobel 1,3 Shaul Atar 1,2,3
1Eliachar Research Laboratory, Galilee Medical Center
2The Cardiology department, Galilee Medical Center
3The Azrieli Faculty of Medicine, Bar-Ilan University

Ultrasound is lately used as therapeutic tool. Therapeutic ultrasound (TUS) physically stimulates biological responses. Studies showed that TUS stimulates angiogenesis; however, its clinical application needs further research. We hypothesized that non-invasive TUS at relevant parameters may augment angiogenesis. We studied several TUS profiles for angiogenesis efficacy. Angiogenesis was evaluated physiologically by Galectin-1 expression and by tube formation.

Methods: We used an in vitro model of human endothelial cells, with or without TUS. In rats we applied permanent ligation of an intra-muscular femoral artery branch. We evaluated ischemia by physiological measurements at baseline, before first TUS treatment and after last treatment. Galectin-1 expression was examined immunohistochemically.

Results: We assessed tube formation by the area occupied by tubes, loops and branching-points number. These parameters were 13.2±3.0%, 19.2±7.2 and 27.5±6.7, respectively, in the control, and increased following f=1MHz I=0.05W/cm2 TUS to 24.2±3.9%, 31.0±5.2 and 34.2±5.1, respectively (P<0.05). Concomitantly, this profile increased pre-treatment perfusion and sum intensity of Galectin-1 expression from 0.06±0.02 ml/min and 45994±38190 pixels to 0.14±0.04 ml/min (~6 folds) and 272835±291155 pixels (~2.3 folds), at final measurements, respectively.

Conclusion: TUS at specific parameters may be used as an adjunct to the current angiogenic methodology or as a new method for augmentation of angiogenesis in chronic ischemic tissues.

Figure 1: HUVEC tube formation assay. A. % Area occupied by tubes, B. Number of loops C. Number of branching points. For each profile a designated column composed of 5 independent experiments (n=5). Baseline - before treatment and Control - without treatment. D-H representetive pictures D. HUVEC before the TUS. E. Without treatment. F. f=1 MHz I=0.03 W/cm2. G. f=1 MHz I=0.07 W/cm2. H. f=1 MHz I=0.05 w/cm2 (x40 magnification). * P<0.05, **P<0.01 and *** P<0.001 vs. the designated group (marked by arrow head).

Figure 1: HUVEC tube formation assay. A. % Area occupied by tubes, B. Number of loops C. Number of branching points. For each profile a designated column composed of 5 independent experiments (n=5). Baseline - before treatment and Control - without treatment. D-H representetive pictures D. HUVEC before the TUS. E. Without treatment. F. f=1 MHz I=0.03 W/cm2. G. f=1 MHz I=0.07 W/cm2. H. f=1 MHz I=0.05 w/cm2 (x40 magnification). * P<0.05, **P

Figure 2: Physiological parameters measured in rat hind-limbs at pre-treatment and in the final measurement. Each treatment group is recognized by its ultrasound frequency (f) on the x axis, intensity (I) on the y axis and on the z axis the magnitude of the parameter is presented A. SpO2, B. HR, C. Perfusion and D. Flow. Each group was given a symbol, which is depicted on the SpO2 plot (white color numbers), significant difference is presented as the symbol of the group over the group it differs of.

Figure 2: Physiological parameters measured in rat hind-limbs at pre-treatment and in the final measurement. Each treatment group is recognized by its ultrasound frequency (f) on the x axis, intensity (I) on the y axis and on the z axis the magnitude of the parameter is presented A. SpO2, B. HR, C. Perfusion and D. Flow. Each group was given a symbol, which is depicted on the SpO2 plot (white color numbers), significant difference is presented as the symbol of the group over the group it differs of.

Offir Ertracht
Offir Ertracht
Galilee Medical Center








Powered by Eventact EMS